Publication | Closed Access
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1
117
Citations
9
References
2018
Year
This study provides Class IV evidence that for patients with SMA1 who are older than 7 months, nusinersen is beneficial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1